Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Random sparse sampling strategy using stochastic simulation and estimation for a population pharmacokinetic study.

Huang XH, Wang K, Huang JH, Xu L, Li LJ, Sheng YC, Zheng QS.

Saudi Pharm J. 2014 Jan;22(1):63-9. doi: 10.1016/j.jsps.2013.01.010. Epub 2013 Feb 10.

PMID:
24493975
[PubMed]
Free PMC Article
2.

Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation.

Hénin E, Tod M, Trillet-Lenoir V, Rioufol C, Tranchand B, Girard P.

Clin Pharmacokinet. 2009;48(6):359-69. doi: 10.2165/00003088-200948060-00002.

PMID:
19650675
[PubMed - indexed for MEDLINE]
3.

[Modeling and simulation activities to design sampling scheme for population pharmacokinetic study on amlodipine].

Zuo XC, Yuan H, Zhang BK, Ng CM, Barrett JS, Yang GP, Huang ZJ, Pei Q, Guo R, Zhou YN, Jing NN, Di W.

Yao Xue Xue Bao. 2012 Jul;47(7):941-6. Chinese.

PMID:
22993862
[PubMed - indexed for MEDLINE]
4.

Experimental design and efficient parameter estimation in population pharmacokinetics.

al-Banna MK, Kelman AW, Whiting B.

J Pharmacokinet Biopharm. 1990 Aug;18(4):347-60.

PMID:
2231324
[PubMed - indexed for MEDLINE]
5.

A comparison of two sparse sampling population pharmacokinetic approaches for the estimation of pharmacokinetic parameters in children.

Mahmood I, Tammara V.

Int J Clin Pharmacol Ther. 2004 Apr;42(4):240-5.

PMID:
15124982
[PubMed - indexed for MEDLINE]
6.

The influence of sparse data sampling on population pharmacokinetics: a post hoc analysis of a pharmacokinetic study of morphine in healthy volunteers.

Ariano RE, Duke PC, Sitar DS.

Clin Ther. 2012 Mar;34(3):668-76. doi: 10.1016/j.clinthera.2012.01.023. Epub 2012 Feb 28.

PMID:
22381713
[PubMed - indexed for MEDLINE]
7.

Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies.

Ette EI, Howie CA, Kelman AW, Whiting B.

Pharm Res. 1995 May;12(5):729-37.

PMID:
7479560
[PubMed - indexed for MEDLINE]
8.

[Estimation of individual pharmacokinetic parameters using maximum a posteriori Bayesian method with D-optimal sampling strategy].

Ding JJ, Jiao Z, Wang Y.

Yao Xue Xue Bao. 2011 Dec;46(12):1493-500. Chinese.

PMID:
22375425
[PubMed - indexed for MEDLINE]
9.

Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis.

Mahmood I, Miller R.

Int J Clin Pharmacol Ther. 1999 Sep;37(9):439-45.

PMID:
10507242
[PubMed - indexed for MEDLINE]
10.

Impact of random and fixed (optimal) sampling approach on the Bayesian estimation of clearance.

Mahmood I.

Int J Clin Pharmacol Ther. 2003 Sep;41(9):392-6.

PMID:
14526763
[PubMed - indexed for MEDLINE]
11.

Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.

Dumont C, Mentré F, Gaynor C, Brendel K, Gesson C, Chenel M.

Clin Pharmacokinet. 2013 Jan;52(1):43-57. doi: 10.1007/s40262-012-0022-9.

PMID:
23212609
[PubMed - indexed for MEDLINE]
12.

Estimation of population pharmacokinetic parameters in the presence of non-compliance.

Mu S, Ludden TM.

J Pharmacokinet Pharmacodyn. 2003 Feb;30(1):53-81.

PMID:
12800807
[PubMed - indexed for MEDLINE]
13.

Population pharmacokinetics. A regulatory perspective.

Sun H, Fadiran EO, Jones CD, Lesko L, Huang SM, Higgins K, Hu C, Machado S, Maldonado S, Williams R, Hossain M, Ette EI.

Clin Pharmacokinet. 1999 Jul;37(1):41-58. Review.

PMID:
10451782
[PubMed - indexed for MEDLINE]
15.

Population pharmacodynamic parameter estimation from sparse sampling: effect of sigmoidicity on parameter estimates.

Pai SM, Girgis S, Batra VK, Girgis IG.

AAPS J. 2009 Sep;11(3):535-40. doi: 10.1208/s12248-009-9131-2. Epub 2009 Jul 24.

PMID:
19629711
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.

Sun H, Ette EI, Ludden TM.

J Pharmacokinet Biopharm. 1996 Dec;24(6):637-50.

PMID:
9300354
[PubMed - indexed for MEDLINE]
17.

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.

Tod M, Mentré F, Merlé Y, Mallet A.

J Pharmacokinet Biopharm. 1998 Dec;26(6):689-716.

PMID:
10485081
[PubMed - indexed for MEDLINE]
18.

Application of optimal sampling theory to the determination of metacycline pharmacokinetic parameters: effect of model misspecification.

Tod M, Padoin C, Louchahi K, Moreau-Tod B, Petitjean O, Perret G.

J Pharmacokinet Biopharm. 1994 Apr;22(2):129-46.

PMID:
7815309
[PubMed - indexed for MEDLINE]
19.

Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Wilhelm AJ, de Graaf P, Veldkamp AI, Janssen JJ, Huijgens PC, Swart EL.

Br J Clin Pharmacol. 2012 Apr;73(4):553-63. doi: 10.1111/j.1365-2125.2011.04116.x.

PMID:
21988410
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials.

Nguyen L, Tranchand B, Puozzo C, Variol P.

Br J Clin Pharmacol. 2002 May;53(5):459-68.

PMID:
11994051
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk